Pancreatic Cancer Research

ResearcherThe University of Texas at AustinNo recent work listed

Zhengrong Cui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1789-910X; OpenAlex author ID A5087576156; NIH RePORTER profile ID 8135888. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
2
Labs led
1
Collaborators
5
Papers, trials and grants by year

2016: 1 grant · 2017: 1 grant · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 1

  1. β-Hydroxy-β-Methylbutyrate Supplementation Promotes Antitumor Immunity in an Obesity Responsive Mouse Model of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13246359↗

Grants 2

  1. Overcoming pancreatic tumor resistance to gemcitabine R01CA135274↗
  2. A Creative Integration of Omega-3 Fatty Acids into Pancreatic Cancer Chemotherapy R21CA179362↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Laura M. Lashinger · 1 shared paper, 2021 · strength 0.13
  2. Kristyn A. Liu · 1 shared paper, 2021 · strength 0.13
  3. Xiaohu Tang · 1 shared paper, 2021 · strength 0.13
  4. Michael F. Coleman · 1 shared paper, 2021 · strength 0.13
  5. Stephen D Hursting · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.